Regulating Off-Label Prescribing
Scholars and practitioners debate whether and how to regulate off-label drug use. In its recent case, FDA v. Alliance for Hippocratic Medicine, the U.S. Supreme Court rejected a challenge to the U.S. Food and Drug Administration’s (FDA) approval of …